TC Biopharm () (TCBPW)
0.01
-0.00 (-18.03%)
At close: Mar 04, 2025, 9:38 AM
TC Biopharm () Balance Sheet Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Cash & Equivalents | 2.46M | 4.81M | 1.57M | 748.01K | 956.5K |
| Short-Term Investments | n/a | n/a | n/a | n/a | n/a |
| Long-Term Investments | n/a | n/a | n/a | n/a | n/a |
| Other Long-Term Assets | n/a | n/a | -1 | n/a | n/a |
| Receivables | n/a | n/a | n/a | n/a | 107.75K |
| Inventory | n/a | n/a | n/a | n/a | n/a |
| Other Current Assets | 4.07M | 836.14K | 811.3K | 230.72K | 242.41K |
| Total Current Assets | 5.7M | 7.45M | 3.86M | 2.22M | 4.22M |
| Property-Plant & Equipment | 2.62M | 3.29M | 3.68M | 4.63M | 5.61M |
| Goodwill & Intangibles | 615.17K | 553.02K | 483.58K | 423.84K | 305.63K |
| Total Long-Term Assets | 3.23M | 3.84M | 4.17M | 5.05M | 5.92M |
| Total Assets | 8.93M | 11.29M | 8.02M | 7.27M | 10.14M |
| Account Payables | 1.85M | 882.36K | 1.42M | 638.37K | 627.93K |
| Deferred Revenue | n/a | n/a | n/a | n/a | n/a |
| Short-Term Debt | 305.32K | 981.52K | 7.57M | 442.7K | 414.63K |
| Other Current Liabilities | 2.46M | 7.3M | 9.61M | 3.11M | 2.84M |
| Total Current Liabilities | 4.75M | 9.16M | 20.58M | 4.19M | 3.88M |
| Long-Term Debt | 2.99M | 1.8M | 2.14M | 2.58M | 3.02M |
| Other Long-Term Liabilities | -1.5M | n/a | n/a | n/a | n/a |
| Total Long-Term Liabilities | 1.5M | 1.8M | 4M | 6.43M | 8.79M |
| Total Liabilities | 6.25M | 10.96M | 24.58M | 10.61M | 12.68M |
| Total Debt | 1.8M | 2.45M | 15.87M | 2.58M | 3.02M |
| Common Stock | 2.06K | 397.49K | 195.48K | 194.58K | 1.78M |
| Retained Earnings | -38.84M | -33.37M | -33.47M | -19.89M | -15.42M |
| Comprehensive Income | n/a | n/a | 16.71M | 16.35M | n/a |
| Shareholders Equity | 2.69M | 331.26K | -16.56M | -3.35M | -2.54M |
| Total Investments | n/a | n/a | n/a | n/a | n/a |